Bile test to diagnose unclear bile duct narrowings
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial uses a bile sample to help diagnose the cause of a bile duct stricture (a narrowing) that was not clearly identified by standard tests. It may help patients avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a bile duct narrowing that has not been clearly diagnosed yet.
- You are between 18 and 90 years old.
- You have already had an ERCP procedure where a biopsy or brush sample was taken from the bile duct.
- You do not have a bleeding disorder.
- You are not pregnant.
- You do not have cancer in another organ that is not related to the bile duct stricture.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a sample of bile (a fluid produced by your liver) can help doctors diagnose bile duct cancer more accurately. If you have a narrowing in your bile duct and need a procedure to take a tissue sample, you may be able to participate.
This study tests a tiny camera and ultrasound probe that can be passed through a scope to look inside the bile duct. It may help doctors better diagnose and treat bile duct narrowings that do not cause jaundice.
This study compares two specialized camera systems (EYEMAX and SPYGLASS DS) used during an endoscopy procedure to diagnose narrowing of the bile ducts. The goal is to see which camera helps doctors better identify and biopsy suspicious tissue in the bile duct.
This study looks at tissue samples from people with bile duct, liver, or pancreas problems to develop better ways to detect cancers in these areas. If you are scheduled for a biopsy, scan, or surgery for a suspected growth in your liver, pancreas, or bile duct, you may be able to help.
This study is testing a new way to use a simple blood test to help diagnose cholangiocarcinoma (bile duct cancer) earlier and more accurately. It is for people whose tumors can be surgically removed and who have not had prior cancer treatment.
This study is testing if a new protein-based lab test can better identify bile duct cancer from stored tissue samples. It's looking for people who had a bile duct sample taken but don't yet have a clear cancer diagnosis.
Hear when a new Cholangiocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.